Pharmacorp Rx Inc. (TSE:PCRX) has released an update. PharmaCorp Rx Inc. has announced the filing of its Q3 2024 financial statements, highlighting its strategic expansion in the Canadian pharmacy market.
Pharmacorp Rx Inc. (TSE:PCRX) has released an update. PharmaCorp Rx Inc. has announced the filing of its Q3 2024 financial statements, highlighting its strategic expansion in the Canadian pharmacy market.
Pharmacorp Rx Inc. (TSE:PCRX) has released an update. PharmaCorp Rx Inc. has successfully completed the acquisition of a pharmacy in Atlantic Canada, with the transaction costing $15.377 million, paid partly
Pharmacorp Rx Inc. (TSE:PCRX) has released an update. Pharmacorp Rx Inc. has announced the acquisition of a fully-owned pharmacy in Atlantic Canada, with the deal comprising a mix of cash
Pharmacorp Rx Inc. (TSE:PCRX) has released an update. Pharmacorp Rx Inc. has successfully acquired a pharmacy in Western Canada, expanding its presence in the region. The purchase was made for
SASKATOON, Saskatchewan, Sept. 03, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated August 22, 2024, it has completed the acquisition of a 90% interest in a pharmacy (the “Acquired Pharmacy”) located in